H10.512

Clinical Causes: Genetic mutations affecting fibrinogen production, leading to abnormal fibrin deposition in tissues Underlying systemic conditions such as ligneous periodontitis or taurin deficiency Chronic inflammation or injury to the conjunctiva that triggers abnormal healing responses Rare cases associated with autoimmune disorders that impair normal tissue repair

Key Symptoms: Persistent conjunctival redness and swelling Formation of thick, woody, or ligneous lesions on the conjunctiva, especially near the eyelids Discomfort or foreign body sensation in the affected eye Blurred or reduced vision due to lesion overgrowth or scarring Frequent episodes of conjunctivitis that do not respond well to conventional treatments Possible crusting or discharge around the eyelid margins

Diagnosis Path: Diagnosis primarily involves a detailed eye examination by an ophthalmologist, including slit-lamp microscopy to visualize the characteristic ligneous lesions. A thorough medical history is taken to identify any systemic conditions or familial history. Laboratory tests such as biopsy of the lesion tissue can confirm the presence of fibrin deposits. Blood tests may be performed to assess fibrinogen levels or identify underlying systemic causes. Differential diagnoses, including other granulomatous or fibrous conjunctivitis, are considered to ensure accurate diagnosis.

Treatment Protocols: Topical corticosteroids to reduce inflammation and lesion formation Immunosuppressive agents or antifibrinolytic drugs in certain cases to control abnormal tissue proliferation Surgical removal of ligneous lesions may be necessary if they are extensive or causing visual impairment Management of underlying systemic conditions, if identified, such as fibrinogen deficiency or autoimmune disorders Regular follow-up visits to monitor lesion progression or recurrence Supportive therapies like lubricating eye drops to maintain ocular comfort